Am J Perinatol 2025; 42(05): 555-563
DOI: 10.1055/a-2419-8476
SMFM Fellowship Series Article

A Pilot Study Using Continuous Glucose Monitoring among Patients with a Low 1-Hour Glucose Challenge Test Result versus Controls to Detect Maternal Hypoglycemia

1   Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
,
Lauren Milley
2   Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York
,
Moeun Son
3   Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York
› Institutsangaben
Funding This study was supported by the internal departmental funding.

Abstract

Objective

A low 1-hour glucose challenge test (GCT) result (<10th percentile for population) has been associated with neonatal morbidity, including small-for-gestational-age birth weight, and it is hypothesized that underlying maternal hypoglycemia may contribute to this neonatal morbidity. We sought to assess whether eligible patients would undergo continuous glucose monitoring to allow comparison of maternal hypoglycemia between those with a low GCT result versus controls.

Study Design

This exploratory study enrolled patients who completed a GCT between 24 and 30 weeks' gestation from June to September 2022. English- or Spanish-speaking participants aged ≥18 years wore a blinded continuous glucose monitor (CGM) for 10 days. There were 10 participants each in the low GCT (<82 mg/dL) and normal GCT group. Proportions were calculated to determine recruitment rates and describe the low versus normal glycemic groups across clinical and sociodemographic characteristics. Maternal hypoglycemia, defined using various proposed thresholds, was analyzed as continuous data (time duration) with Student's t-tests and categorical data (number of episodes) with chi-square tests and bivariate analyses were performed comparing participants with a low versus normal GCT. Primary outcome measures were recruitment, enrollment, and adherence rates, and overall glycemic values for each group.

Results

Of 64 eligible patients, 58 (91%) were approached, and of them, 20 (35%) were enrolled. All 20 participants had CGM data to review with 100% adherence. Average glucose values were similar between participants in the low GCT and normal GCT groups (111.7 ± 18.0 vs. 111.6 ± 11.7 mg/dL, p = 0.99), and participants with a low GCT value did not demonstrate more hypoglycemia than those with a normal GCT value across five proposed thresholds on CGM analysis.

Conclusion

In this pilot study, participants wore blinded CGMs to collect glycemic data, and those with a low GCT result did not experience more hypoglycemia than those with a normal GCT on CGM analysis.

Key Points

  • Study participants wore continuous glucose monitors in blinded mode to gather glycemic data with 100% adherence.

  • Participants with a low GCT result (<82 mg/dL) as compared with those with a normal GCT result were not more likely to demonstrate maternal hypoglycemia using several thresholds on CGM analysis.

  • In our cohort, there were few participants in either glycemic group who reported food insecurity or lived in a food desert.

Note

Dexcom Inc. provided 6th generation continuous glucose monitors at subsidized cost but had no input in the design of the study, data analysis or interpretation, or manuscript writing.


Supplementary Material



Publikationsverlauf

Eingereicht: 22. April 2024

Angenommen: 20. September 2024

Artikel online veröffentlicht:
16. Oktober 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004; 103 (06) 1229-1234
  • 2 ACOG practice bulletin no. 190: gestational diabetes. Obstet Gynecol 2018; 131 (02) e49-e64
  • 3 Metzger BE, Lowe LP, Dyer AR. et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
  • 4 Saravanan P. Diabetes in Pregnancy Working Group. Maternal Medicine Clinical Study Group, Royal College of Obstetricians and Gynaecologists, UK. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol 2020; 8 (09) 793-800
  • 5 Calfee EF, Rust OA, Bofill JA, Ross EL, Morrison JC. Maternal hypoglycemia: is it associated with adverse perinatal outcome?. J Perinatol 1999; 19 (05) 379-382
  • 6 Ma KK, Mele L, Landon MB. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The obstetric and neonatal implications of a low value on the 50-g glucose screening test. Am J Perinatol 2013; 30 (09) 715-722
  • 7 Melamed N, Hiersch L, Peled Y, Hod M, Wiznitzer A, Yogev Y. The association between low 50 g glucose challenge test result and fetal growth restriction. J Matern Fetal Neonatal Med 2013; 26 (11) 1107-1111
  • 8 Shinohara S, Hirai M, Hirata S, Suzuki K. Relation between low 50-g glucose challenge test results and small-for-gestational-age infants. J Obstet Gynaecol Res 2015; 41 (11) 1752-1756
  • 9 Budak MŞ, Araç E. Maternal hypoglycaemia on the 50 g oral glucose challenge—evaluation of obstetric and neonatal outcomes. Ginekol Pol 2018; 89 (07) 370-374
  • 10 Mitta M, Sanchez-Ramos L, Roeckner JT, Bennett S, Kovacs A, Kaunitz AM. A low 50-gram, 1-hour glucose challenge test value predicts neonatal birth weight less than the 10th percentile: a systematic review and meta-analysis. Am J Perinatol 2021; 38 (08) 841-847
  • 11 Ding JJ, Lundsberg LS, Culhane JF, Patridge C, Milley L, Son M. The association between a low 50-gram, 1-hour glucose challenge test value and neonatal morbidity. J Matern Fetal Neonatal Med 2023; 36 (02) 2245527
  • 12 Persson B, Hansson U. Hypoglycaemia in pregnancy. Baillieres Clin Endocrinol Metab 1993; 7 (03) 731-739
  • 13 Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000; 54 (Suppl. 01) S47-S51
  • 14 Herrera E, Muñoz C, López-Luna P, Ramos P. Carbohydrate-lipid interactions during gestation and their control by insulin. Braz J Med Biol Res 1994; 27 (11) 2499-2519
  • 15 Martin A, Zorzano A, Caruncho I, Herrera E. Glucose tolerance tests and “in vivo” response to intravenous insulin in the unanaesthesized late pregnant rat and their consequences to the fetus. Diabete Metab 1986; 12 (06) 302-307
  • 16 Sferruzzi-Perri AN, Vaughan OR, Forhead AJ, Fowden AL. Hormonal and nutritional drivers of intrauterine growth. Curr Opin Clin Nutr Metab Care 2013; 16 (03) 298-309
  • 17 Jensen VFH, Mølck AM, Lykkesfeldt J, Bøgh IB. Effect of maternal hypoglycaemia during gestation on materno-foetal nutrient transfer and embryo-foetal development: evidence from experimental studies focused primarily on the rat. Reprod Toxicol 2018; 77: 1-24
  • 18 Feig DS, Donovan LE, Corcoy R. et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017; 390 (10110): 2347-2359
  • 19 Battarbee AN, Sauer SM, Sanusi A, Fulcher I. Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes. Am J Obstet Gynecol 2024; 231 (01) 122.e1-122.e9
  • 20 Kusinski LC, Brown J, Hughes DJ, Meek CL. Feasibility and acceptability of continuous glucose monitoring in pregnancy for the diagnosis of gestational diabetes: a single-centre prospective mixed methods study. PLoS One 2023; 18 (09) e0292094
  • 21 Di Filippo D, Henry A, Bell C. et al. A new continuous glucose monitor for the diagnosis of gestational diabetes mellitus: a pilot study. BMC Pregnancy Childbirth 2023; 23 (01) 186
  • 22 Gomez H, DiTosto JD, Niznik CM, Yee LM. Understanding food security as a social determinant of diabetes-related health during pregnancy. Am J Perinatol 2023; 40 (08) 825-832
  • 23 Laraia BA, Siega-Riz AM, Gundersen C. Household food insecurity is associated with self-reported pregravid weight status, gestational weight gain, and pregnancy complications. J Am Diet Assoc 2010; 110 (05) 692-701
  • 24 Kahr MK, Suter MA, Ballas J. et al. Geospatial analysis of food environment demonstrates associations with gestational diabetes. Am J Obstet Gynecol 2016; 214 (01) 110.e1-110.e9
  • 25 Young C, Laurent O, Chung JH, Wu J. Geographic distribution of healthy resources and adverse pregnancy outcomes. Matern Child Health J 2016; 20 (08) 1673-1679
  • 26 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
  • 27 Screening and diagnosis of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline no. 4. Obstet Gynecol 2023; 141 (06) 1232-1261
  • 28 U.S. household food security survey module: six-item short form economic research service, USDA. Accessed February 27, 2022 at: https://www.ers.usda.gov/media/8282/short2012.pdf
  • 29 Paluchamy T. Hypoglycemia: essential clinical guidelines. Blood Glucose Levels, IntechOpen, January 8, 2020
  • 30 Hedderson M, Ehrlich S, Sridhar S, Darbinian J, Moore S, Ferrara A. Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care 2012; 35 (07) 1492-1498
  • 31 Sridhar SB, Ferrara A, Ehrlich SF, Brown SD, Hedderson MM. Risk of large-for-gestational-age newborns in women with gestational diabetes by race and ethnicity and body mass index categories. Obstet Gynecol 2013; 121 (06) 1255-1262
  • 32 Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59
  • 33 Dexcom G6. Accessed March 5, 2024 at: https://dexcompdf.s3-us-west-2.amazonaws.com/HCP_Website/Dexcom+G6+Pro+Resources/LBL017522_G6_Pro_log_sheet.pdf
  • 34 UDSA Food Access Research Atlas. Accessed February 27, 2022 at: https://www.ers.usda.gov/data-products/food-access-research-atlas/go-to-the-atlas/
  • 35 Danne T, Nimri R, Battelino T. et al. International consensus on the use of continuous glucose monitoring. Diabetes Care 2017; 40 (12) 1631-1640
  • 36 Shah VN, DuBose SN, Li Z. et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab 2019; 104 (10) 4356-4364
  • 37 Bartal MF, Cornthwaite JA, Ghafir D. et al. Continuous glucose monitoring in individuals undergoing gestational diabetes screening. Am J Obstet Gynecol 2023; 229 (04) 441.e1-441.e14
  • 38 Poverty in New Haven. Connecticut. Welfare Info. Accessed March 29, 2022 at: https://www.welfareinfo.org/poverty-rate/connecticut/new-haven#:~:text=The%20poverty%20rate%20in%20New%20Haven%20is%2025.6%25.,line%20in%20the%20last%20year
  • 39 Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009